Thai Consensus on Venous Thromboembolism in Hip and Knee Surgery
Increasing numbers of hip and knee arthroplasty may associate with higher risk of complications such as venous thromboembolism. Most of Thai orthopedic surgeons ignore thromboprophylaxis because of less symptomatic VTE in Asian population. The Thai consensus on venous thromboembolism in hip and knee surgery consist of twenty-four common questions about VTE including their supported literatures. The gold standard of diagnosis is contrast venography although the duplex ultrasound has more role in postoperative patients. Thai patients undergoing hip and knee surgery seem to have lower prevalence of VTE than Caucasian. However, mechanical or chemoprophylaxis should be considered especially in the high risk group and hip fracture in elderly.
Rolfe MW, Solomon DA. Lower extremity venography: still the gold standard. Chest 1999 Oct;116(4):853-4.
McRae SJ, Ginsberg JS. The diagnostic evaluation of deep vein thrombosis. Am Heart Hosp J 2004 Fall;2(4):205-10.
American Academy of Orthopedic Surgeons (AAOS) “Deep Vein Thrombosis” [Online]. Available: http://orthoinfo.aaos.org/topic.cfm?topic=a002192015.
Gao FQ, Li ZJ, Zhang K, Huang D, Liu ZJ. Risk factors for lower limb swelling after primary total knee arthroplasty. Chin Med J (Engl) 2011;124(23):3896-9.
Wells PS, Brill-Edwards P, Stevens P. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation 1995;91:2184-87.
Freyburger G, Trillaud H, Labrouche S. D-dimer strategy in thrombosis exclusion -- a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost 1998;79:32-37.
Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost 1999;82:688-694.
Rafee A, Herlikar D, Gilbert R, Stockwell R, McLauchlan G. D-Dimer in the diagnosis of deep vein thrombosis following total hip and knee replacement: A prospective study. Annals of The Royal College of Surgeons of England 2008;90(2):123–26.
Abraham P, Ternisien C, Hubert L, Pidhorz L, Saumet JL. Does venous microemboli detection add to the interpretation of D-dimer values following orthopedic surgery? Ultrasound Med Biol 1999;25(4):637-40.
Bounameaux H, Miron MJ, Blanchard J, de MP, Hoffmeyer P, Leyvraz PF. Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis 1998;9(8):749-52.
Niimi R, Hasegawa M, Sudo A, Shi D, Yamada T, Uchida A. Evaluation of soluble fibrin and D-dimer in the diagnosis of postoperative deep vein thrombosis. Biomarkers 2010;15(2):149-57.
Bara L, Planes A, Samama MM. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 1999;104(2):230-40.
Bongard O, Wicky J, Peter R. D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res 1994;74(5):487-93.
Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement. Thromb Haemost 1998;79(3):509-10.
Maezawa K, Nozawa M, Aritomi K, Kubota M, Shitoto K, Kurosawa H. Changes of D- dimer after total hip arthroplasty in patients with and without intraoperative heparin. Arch Orthop Trauma Surg 2008;128(1):37-40.
Shiota N, Sato T, Nishida K. Changes in LPIA D-dimer levels after total hip or knee arthroplasty relevant to deep-vein thrombosis diagnosed by bilateral ascending venography. J Orthop Sci 2002;7(4):444-50.
Yoo MC, Cho YJ, Ghanem E, Ramteke A, Kim KI. Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool. Arch Orthop Trauma Surg 2009;129(7):887-94.
Lensing AW, Prandoni P, Brandjes D. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320(6):342-45.
Mattos MA, Londrey GL, Leutz DW. Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis. J Vasc Surg 1992;15(2):366-75.
Le Gal G, Righini M, Sanchez O. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006;95(6):963-66.
Schellong SM, Beyer J, Kakkar AK. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost 2007 Jul;5(7):1431-7.
Mont MA, Jacobs JJ, Boggio LN, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AJ Jr, Watters WC 3rd, Turkelson CM, Wies JL, Donnelly P, Patel N, Sluka P; AAOS. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty, evidence-based guideline?and evidence report: J Am Acad Orthop Surg 2011 Dec;19(12):768-76.
Schmidt B, Michler R, Klein M, Faulmann G, Weber C, Schellong S. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial. Thromb Haemost 2003 Nov;90(5):949-54.
Pellegrini VD Jr, Donaldson CT, Farber DC. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res 2006;452:21-7.
Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, Yates AC Jr, Boggio LN, Watters WC 3rd, Turkelson CM, Wies JL, Sluka P, Hitchcock K. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am 2012 Apr 18;94(8):746-7.
Nejat EJ, Polotsky AJ, Pal L. Predictors of chronic disease at midlife and beyond—the health risks of obesity. Maturitas 2010; 65:106–11.
Kabrhel C, Varraso R, Goldhaber SZ, Rimm EB, Camargo CA. Prospective study of BMI and the risk of pulmonary embolism in women. Obesity 2009;17:2040–46.
Eichinger S, Hron G, Bialonczyk C, Hirschl M, Minar E, Wagner O, et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Int Med 2008;168:1678–83.
Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: A Danish follow-up study. Circulation 2009;120:1850–57.
Barba R, Zapatero A, Losa JE, Valdes V, Todoli JA, Di Micco P, et al. Body mass index and mortality in patients with acute venous thromboembolism: Findings from the RIETE registry. J Thromb Haemost 2008;6:595–600.
Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox. Thromb Res 2011;128:518–23.
Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007;10:433–42.
García-Raso A, Llamas Sillero P. Elevated body fat is a risk factor for venous thromboembolism and thrombotic complications. Epidemiol Rep 2014;2:3.
Eikelboom JW, Weitz JI. Importance of family history as a risk factor for venous thromboembolism. Circulation 2011;124:996–97.
Osinbowale O, Ali L, Chi YW. Venous thromboembolism: A clinical review. Postgrad Med 2010;122:54–65.
Martin GM, Thornhill TS, Katz JN. Complications of total knee arthroplasty. In: Post TW, editor. UpToDate. Waltham, MA: UpToDate; 2015.
Erens GA, Thornhill TS, Katz JN. Complications after total hip arthroplasty. In: Post TW, editor. UpToDate. Waltham, MA: UpToDate; 2015.
Kanchanabat B, Stapanavatr W, Meknavin S, Soorapanth C, Sumanasrethakul C, Kanchanasuttirak P. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg 2011;98(10):1356-64.
Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, Reumthantong A. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty. J Med Assoc Thai 2007;90(7):1342-7.
Charoencholvanich K, Siriwattanasakul P, Tranexamic acid reduces blood loss and blood transfusion after TKA: A prospective randomized controlled trial. Clin Orthop Relat Res 2011 Oct; 469(10):2874–80.
Gandhi R. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Research Notes 2013;6:184.
Lin ZX, Woolf SK. Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics 2016 Mar;39(2):119-30.
Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis and diagnosis. Clin Orthop 1989;242:212–31.
Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of the hip: the East Anglian audit. Br Med J 1995;310:904–8.
Zahn HR, Skinner JA, Porteous MJ. The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation. Injury 1999;30:605–7.
Hefley FG Jr, Nelson CL, Puskarich-May CL. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip. J Bone Joint Surg Am 1996 Apr; 78(4):581-3.
Lee S, Hwang JI, Kim Y, Yoo JJ. Venous thromboembolism following hip and knee replacement arthroplasty in Korea: A nationwide study based on claims registry. J Korean Med Sci 2016 Jan;31(1):80-88.
Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br 2009;91(7):935-42.
Atchabahian A, Schwartz G, Hall CB, Lajam CM, Andreae MH. Regional analgesia for improvement of long-term functional outcome after elective large joint replacement. Cochrane Database Syst Rev w2015;(8):CD010278.
Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001;38(2Suppl5):12-9.
Haas SB, Barrack RL, Westrich G. Venous thromboembolic disease after total hip and knee arthroplasty. Instr Course Lect 2009;58:781-93.
Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br 2000;82(6):795-800.
Hernandez AJ, Almeida AM. The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty. Clin Sci 2012;67(9):1053-57.
Lacut K, La Revue du Praticien. Mechanical prophylaxis of venous thromboembolism 2011;61(9):1232-36. Europe PMC.org
Leme LEG, Sguizzatto GT. Prophylaxis of venous thromboembolism in orthopaedic surgery. Rev Bras Ortop 2012;47(6):685–93.
MacLellan DG, Fletcher JP. Mechanical compression in the prophylaxis of venous thromboembolism. ANZ J Surg 2007 Jun;77(6):418-23.
Parvizi J, Azzam K, Rothman RH. Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines. J Arthroplasty 2008;23(7Suppl):2.
Sharrock NE, Gonzalez Della Valle A, Go G, et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 2008;466:714.
Walsh M, Preston C, Bong M, et al. Relative risk factors for requirement of blood transfusion after total hip arthroplasty. J Arthroplasty 2007;22:1162.
Freedman KB, Brookenthal KR, Fitzgerald Jr RH, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000;82-A:929.
Kim YH, Kulkarni SS, Park JW, Kim JS. Prevalence of deep vein thrombosis and pulmonary embolism treated with mechanical compression device after total knee arthroplasty in Asian patients. J Arthroplasty 2015;30:1633–37.
Lee WS, Kim KI, Lee HJ. The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remain low. A meta-analysis. Clin Orthop Relat Res 2013;471:1523.
Pour AE, Keshavarzi NR, Purtill JJ, Sharkey PF, Parvizi J. Is venous foot pump effective in prevention of thromboembolic disease after joint arthroplasty: a meta-analysis. J Arthroplasty 2012 Oct 24. pii: S0883–5403(12)00571-2.
Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST Journal 2012 Feb 1;141(2_suppl):e278S-325S.
An VV, Phan K, Levy YD, Bruce WJ. Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis. J Arthroplasty 2016 Apr 13 Epub.
Rodgers A, MacMahon S, Collins R, Prentice C. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295–302.
Drescher FS, Sirovich BE, Lee A, Morrison DH, Chiang WH, Larson RJ. Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis. J Hosp Med 2014 Sep;9(9):579-85.
Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty. J Bone Joint Surg Am 2013;95-A:1256–64.
Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, et al. Rivaroxaban vs enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358:2776–86.
Eriksson BI, Borris LC, Friedman RJ, Haas S, HuismanMV, Kakkar AK, et al. Rivaroxaban vs enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008;358:2765–75.
Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med 2009;361:594–604.
Russell RD, Huo MH. Apixaban and rivaroxaban decrease deep vein thrombosis but not other complications after total hip and total knee arthroplasty. J Arthroplasty 2013;28:1477–81.
Ma G, Zhang R, Wu X, Wang D, Ying K. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials. Thromb Res 2015;135:816–22.
Takeshi FJ, Ching-Jen W, Yohko K, Mashio N, Tetsuya K, Kei I, Hitoshi U, Kenji A, Shintaro T. Safety and efficacy of edoxaban, an oral factor xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial:A randomized, double-blind, double-dummy study. Thromb Res 2014;134:1198–204.
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, Van Dijk CN, Frostick SP. Oral dabigatranetexilate vs subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 2007;5:2178-85.
Lotke PA, Palevsky H, Keenan AM. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop 1996;324:251-8.
Nordstrom BL, Kachroo S, Fraeman KH, Nutescu EA, Schein JR, Fisher A, Bookhart BK. Warfarin prophylaxis in patients after total knee or hip arthroplasty – international normalized ratio patterns and venous thromboembolism, Curr Med Res Opin 2011;27:10,1973-85.
Heit JA, Berkowitz SD, Bona R, Cabanas V, Corson JD, Elliott CG. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared with warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Thromb Haemost 1997;77:32–8.
Fitzgerald Jr RH, Spiro TE, Trowbridge AA, Gardiner Jr GA, Whitsett TL, O’Connell MB.Prevention of venous thrombo-embolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 2001;83:900–6.
Leclerc JR, Geerts WH, Desjardins L. Prevention of deep vein thrombosis after major knee surgery—a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992;67(4):417-23.
Turpie AG, Levine MN, Hirsh J. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315(15):925-9.
Eikelboom JW, Quinlan DJ, Douketis JD. Extended duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358(9275):9-15.
Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348:224–28.
Hull RD, Pineo GF, Stein PD. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001;135(10):858-69.
Steele MJ, Fox JS, Fletcher JP, Grigg LE, Bell G. Clopidogrel dilemma for orthopaedic surgeons. ANZ J Surg 2011;81(11):774-84.
Anielski R, Barczynski M. [Postoperative wound infections. II. Risk factors related to surgery]. Przegl Lek 1998;55:109–19.
Saleh K, Olson M, Resig S. Predictors of wound infection in hip and knee joint replacement: results from a 20-year surveillance program. J Orthop Res 2002;20:506–15.
Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does ‘excessive’ anticoagulation predispose to periprosthetic infection? J Arthroplasty 2007;22(Suppl2):24–8.
Venous thromboembolism; Reducing the risk. NICE Clinical guideline 2012(National Institute for Health and Clinical Excellence).
Morris JK, Fincham BM. Intermittent pneumatic compression for venous thromboembolism prophylaxis in total knee arthroplasty. Orthopedics 2012;35(12):1716-1721.
Hamilton WG, Reeves JD, Fricka KB, Goyal N, Engh GA, Parks NL. Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty. J Arthroplasty. 2015 Jan 31;30(1):43-5.
Lieberman JR, Pensak MJ. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2013 Oct 2;95(19):1801-11.
Forster R, Stewart M. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Cochrane Database Syst Rev. 2016 Mar 30;3.CD004179.
Farfan M, Bautista M, Bonilla G, Rojas J, Llinás A, Navas J. Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of literature and meta-analysis. Thromb Res 2016;141:163–70.
Kwong LM. Hip fracture and venous thromboembolism in the elderly. J Surg Orthop Adv 2004 Fall;13(3):139-48.
Jeong GK, Gruson KI, Egol KA, Aharonoff GB, Karp AH, Zuckerman JD, Koval KJ. Thromboprophylaxis after hip fracture: evaluation of 3 pharmacologic agents. Am J Orthop (Belle Mead NJ) 2007 Mar;36(3):135-40.
Qi Z, Yiqin Z, Haishan W, Yuli W, Qirong Q, Hui Z, Yunli Z, Peiliang F. Changes of hemoglobin and hematocrit in elderly patients receiving lower joint arthroplasty without allogeneic blood. Chi Medical J 2015 Jan;128(1):75-8.
Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. J Bone Joint Surg Br 2004;86-B:561-5.
Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006 Dec;135(5):634-41.
Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet J. Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008 May;64(5):1211-7.
National Guideline Clearinghouse (NGC) and the Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism prophylaxis. Nov 2003
Szekendi M. Early Ambulation Reduces the Risk of Venous Thromboembolism after Total Knee Replacement. ANA 7th Annual Nursing Quality. Conference, February 2013.
Copyright (c) 2017 Journal of Southeast Asian Medical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright to all published articles will be held by The Journal Medical Research. Copyright forms are handled by the production department of the publisher once a manuscript is accepted and scheduled for publication.